Calidi Biotherapeutics Inc./$CLDI
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
Ticker
$CLDI
Sector
Primary listing
AMEX
Industry
Biotechnology
Headquarters
Employees
28
ISIN
US3207033099
Website
CLDI Metrics
BasicAdvanced
$8.3M
-
-$1.55
1.06
-
Price and volume
Market cap
$8.3M
Beta
1.06
52-week high
$0.95
52-week low
$0.20
Average daily volume
1.3M
Financial strength
Current ratio
2.117
Quick ratio
1.956
Long term debt to equity
30.854
Total debt to equity
64.461
Interest coverage (TTM)
-26.71%
Profitability
EBITDA (TTM)
-19.695
Effective tax rate (TTM)
-0.06%
Management effectiveness
Return on assets (TTM)
-111.74%
Return on equity (TTM)
551.17%
Valuation
Price to book
1.19
Price to tangible book (TTM)
1.13
Price to free cash flow (TTM)
-0.148
Free cash flow yield (TTM)
-674.13%
Free cash flow per share (TTM)
-165.70%
Growth
Earnings per share change (TTM)
-87.78%
CLDI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Calidi Biotherapeutics Inc. stock?
Calidi Biotherapeutics Inc. (CLDI) has a market cap of $8.3M as of July 06, 2025.
What is the P/E ratio for Calidi Biotherapeutics Inc. stock?
The price to earnings (P/E) ratio for Calidi Biotherapeutics Inc. (CLDI) stock is 0 as of July 06, 2025.
Does Calidi Biotherapeutics Inc. stock pay dividends?
No, Calidi Biotherapeutics Inc. (CLDI) stock does not pay dividends to its shareholders as of July 06, 2025.
When is the next Calidi Biotherapeutics Inc. dividend payment date?
Calidi Biotherapeutics Inc. (CLDI) stock does not pay dividends to its shareholders.
What is the beta indicator for Calidi Biotherapeutics Inc.?
Calidi Biotherapeutics Inc. (CLDI) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.